Cardiac Biotech Solutions, Inc. (OTCID: CBSC) (“CBSC” or the “Company”), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring products, today provided an update on ...
According to Cardiac Event Monitor Markets: Market Shares, Strategies, and Forecasts, 2017 to 2023 report, growth is based on implementation of devices that measure cardiac function over a period of a ...
LAS VEGAS, NV / ACCESS Newswire / February 25, 2025 / CB Scientific, Inc. (CBSC) (OTC PINK:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac ...
ESCONDIDO, CA / ACCESSWIRE / September 6, 2022 / CB Scientific. Inc.(OTCQB:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring ...
ESCONDIDO, CA / ACCESSWIRE / May 24, 2022 / CB Scientific. Inc. (OTCQB:CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products ...
PaceMate delivers a patient management solution that addresses the full cardiac device care continuum. SARASOTA, Fla., May 19, 2023 /PRNewswire/ -- PaceMate ® announced today its collaboration with ...
The "Cardiac Monitoring Market - Focused Insights 2025-2030" report has been added to ResearchAndMarkets.com's offering. The Cardiac Monitoring Market was valued at USD 8.24 billion in 2024, and is ...
The peer-reviewed manuscript, titled “Comparative Effectiveness and Healthcare Utilization for Ambulatory Cardiac Monitoring (ACM) Strategies in Medicare Beneficiaries,” reveals that the Zio long-term ...
Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups. Latest data showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results